Cargando…
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Intratumour heterogeneity (ITH) is pervasive across all cancers studied and may provide the evolving tumour multiple routes to escape immune surveillance. Immune checkpoint inhibitors (CPIs) are rapidly becoming standard of care for many cancers. Here, we discuss recent work investigating the influe...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253787/ https://www.ncbi.nlm.nih.gov/pubmed/33631295 http://dx.doi.org/10.1016/j.semcancer.2021.02.013 |